title: Contact dermatitis to levobunolol eyedrops superimposed on IgE-mediated rhinoconjunctivitis.
authors.forename: Brooke
authors.initials: B
authors.lastname: Blumetti
authors.forename: Robert T
authors.initials: RT
authors.lastname: Brodell
authors.forename: Stephen E
authors.initials: SE
authors.lastname: Helms
authors.forename: Linda P
authors.initials: LP
authors.lastname: Brodell
authors.forename: Donald L
authors.initials: DL
authors.lastname: Bredle
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D000368:Aged; D015897:Comorbidity; D003231:Conjunctivitis / Q000175:diagnosis; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis / Q000209:etiology*; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D002040:Levobunolol / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D009883:Ophthalmic Solutions; D012220:Rhinitis / Q000175:diagnosis
chemical_list: D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D007073:Immunoglobulin E; D002040:Levobunolol